Archives: Press

Neucore Bio Awarded Competitive Grant from the U.S. National Science Foundation for Research on Scalability of Exosome-based Therapeutics for Genetic Disease
Neucore Bio Awarded U.S. National Institutes of Health (NIH) STTR Phase I Grant to Pursue Exosome-based Genetic Medicine for Charcot-Marie-Tooth Disease Type 1A (CMT1A)
New Ohio Angel Fund closes inaugural round, bets early on AI and data privacy startups
Neucore Bio Awarded Competitive Grant from the U.S. National Science Foundation for Research on Scalability of Exosome-based Therapeutics for Genetic Disease
Clarametyx Biosciences Announces FDA Grant Of Fast Track And Qualified Infectious Disease Product Designations For CMTX-101
Kristy Campbell is driven to help startups
Clarametyx Biosciences Announces Positive Interim Analysis in Phase 2a Study Evaluating CMTX-101 for Infections Associated with Cystic Fibrosis
50 Columbus-Based Startups on Display at Annual Innovation Hop
Rev1’s Innovation Hop: Bold startups. Big ideas. One night only.
1 2 3 106